Like CML, Myelofibrosis (MF) is another rare disorder in the family of Myeloproliferative Neoplasms (MPN’s).
The CML Society of Canada is expanding our reach to provide support to patients with MF and to help them find a voice of their own, while being supported with our voices.
The incidence of MF in Canada is very rare, 1 in 1,000,000. This is why The CML Society of Canada wants to play an active role with our fellow MPN – MF patients. Together our voices will be united and stronger.
Quality of Life Survey for patients with Myelofibrosis
For the FACT sheet on Myelofibrosis
For information on the latests treatment for Myelofibrosis JAKAVI®
For information on drug coverage in Canada Treatment Access
Please do not forget to register for our newsletters by using the forms on this website.
